Rush for diabetes and weight-loss drug Ozempic puts cross-border sales in spotlight
The B.C. government's bid to restrict the sale of diabetes drug Ozempic to prevent non-Canadian residents draining supplies was the right move and a long time coming, says Brett Skinner, founder and CEO of the Canadian Health Policy Institute.
